Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Niban apoptosis regulator 3 (NIBAN3), also known as BCNP1 or FAM129C, is a protein-coding gene found in Homo sapiens, with a prominent expression in immune tissues, especially B cells[3][6][7]. NIBAN3 is a member of the Niban protein family and shares homology with NIBAN1. Experimental functional characterization is limited: some evidence from mouse models and interaction partner analysis suggests a possible role in B-cell development, receptor signaling, and immune regulation, but knockout mouse data do not clearly confirm its biological function[1][4][10]. NIBAN3 is not currently classified as a therapeutic target, and there are no drug development programs or approved therapies directed against it. Its relevance as a disease biomarker, therapeutic safety profile, or drug interactome has not been established to date[3][6][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Niban apoptosis regulator 3 (NIBAN3).